Profusa, Inc. (PFSA)
NASDAQ (NMS) NASDAQ (NMS) Primary Summary
Analyzing Profusa (NASDAQ:PFSA) & Medline (NASDAQ:MDLN)
Medline (NASDAQ: MDLN - Get Free Report) and Profusa (NASDAQ: PFSA - Get Free Report) are both manufacturing companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, profitability, analyst recommendations, earnings, valuation and risk. Profitability This table compares Medline and Profusa's net margins, return
Profusa, Inc. (PFSA) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Profusa, Inc. ever had a stock split?
Profusa, Inc. Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | Jack E. Stover CEO | NASDAQ (NMS) Exchange | 74319X207 CUSIP |
| US Country | 2 Employees | - Last Dividend | 17 Aug 2026 Last Split | - IPO Date |
Overview
A digital-health company is at the forefront of innovation by developing advanced tissue-integrating biosensors like the Lumee™ Oxygen Platform. This platform is designed to provide continuous monitoring of body chemistry, allowing for real-time tracking of health metrics. By harnessing the power of artificial intelligence, the company aims to offer valuable health insights that empower individuals managing chronic conditions. The primary focus is on effectively addressing health issues such as diabetes and critical limb ischemia, helping patients to maintain better control over their health and enhance their quality of life.
Products and Services
- Lumee™ Oxygen Platform
The Lumee™ Oxygen Platform is a state-of-the-art biosensor designed to integrate seamlessly with human tissue. It continuously monitors oxygen levels in the body, providing critical data that can inform healthcare decisions and treatment plans.
- Chronic Condition Management
This service focuses on leveraging AI-based insights to help patients manage chronic illnesses like diabetes and peripheral artery disease effectively. The approach includes personalized feedback based on real-time health data, guiding users towards better health outcomes.
- Data Analytics and Insights
Utilizing robust data analytics, the company converts raw health data into actionable insights. This service provides healthcare professionals and patients with valuable information that can lead to improved management of health conditions and decision-making.
- Remote Patient Monitoring
This service includes remote monitoring capabilities, enabling healthcare providers to track patients' health indicators in real-time. It integrates with the biosensing technology to ensure that vital metrics are monitored consistently, allowing for timely interventions when necessary.
- Patient Education and Support
The company offers educational resources and support programs to inform patients about their health conditions. This service aims to increase health literacy, ensuring patients understand their biosensor readings and the implications for their health.
Contact Information
